American International Group, Inc. Phathom Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$6.21 - $11.05 $844 - $1,502	-136 Reduced 0.85%	15,802 $167,000
Q4 2023 Feb 13, 2024	BUY	$6.99 - $10.71 $3,697 - $5,665	529 Added 3.43%	15,938 $145,000
Q3 2023 Nov 13, 2023	BUY	$10.26 - $15.7 $36,556 - $55,939	3,563 Added 30.08%	15,409 $159,000
Q2 2023 Aug 04, 2023	BUY	$7.28 - $14.32 $43 - $85	6 Added 0.05%	11,846 $169,000
Q1 2023 May 12, 2023	BUY	$6.19 - $12.36 $1,460 - $2,916	236 Added 2.03%	11,840 $84,000
Q4 2022 Feb 10, 2023	BUY	$9.18 - $11.53 $6,159 - $7,736	671 Added 6.14%	11,604 $130,000
Q3 2022 Nov 14, 2022	BUY	$6.46 - $12.11 $1,001 - $1,877	155 Added 1.44%	10,933 $121,000
Q2 2022 Aug 12, 2022	BUY	$6.2 - $15.5 $4,482 - $11,206	723 Added 7.19%	10,778 $91,000
Q1 2022 May 13, 2022	SELL	$11.55 - $20.06 $8,177 - $14,202	-708 Reduced 6.58%	10,055 $137,000
Q4 2021 Feb 11, 2022	SELL	$17.83 - $33.15 $5,741 - $10,674	-322 Reduced 2.9%	10,763 $212,000
Q3 2021 Nov 12, 2021	SELL	$30.69 - $36.83 $8,071 - $9,686	-263 Reduced 2.32%	11,085 $356,000
Q2 2021 Aug 13, 2021	BUY	$32.66 - $39.87 $150,268 - $183,441	4,601 Added 68.19%	11,348 $384,000
Q1 2021 May 07, 2021	BUY	$33.86 - $48.68 $16,997 - $24,437	502 Added 8.04%	6,747 $253,000
Q4 2020 Feb 12, 2021	SELL	$33.22 - $50.26 $5,946 - $8,996	-179 Reduced 2.79%	6,245 $207,000
Q3 2020 Nov 04, 2020	SELL	$29.24 - $40.19 $4,269 - $5,867	-146 Reduced 2.22%	6,424 $236,000
Q2 2020 Aug 12, 2020	BUY	$25.06 - $54.6 $5,012 - $10,920	200 Added 3.14%	6,570 $216,000
Q1 2020 May 04, 2020	SELL	$24.65 - $42.83 $9,071 - $15,761	-368 Reduced 5.46%	6,370 $164,000
Q4 2019 Feb 05, 2020	BUY	$18.59 - $37.67 $125,259 - $253,820	6,738 New	6,738 $210,000

Others Institutions Holding PHAT

# of Institutions

123

Shares Held

59M

Call Options Held

467K

Put Options Held

34.9K

Frazier Life Sciences Management, L.P. Menlo Park, CA

10.1M
Shares

$183 Million
6.14% of portfolio
Medicxi Ventures Management (Jersey) LTD

7.46M
Shares

$135 Million
27.45% of portfolio
Carlyle Group Inc. Washington, DC

3.5M
Shares

$63.2 Million
4.3% of portfolio
Invesco Ltd. Atlanta, GA

3.14M
Shares

$56.8 Million
0.01% of portfolio
Black Rock Inc. New York, NY

2.93M
Shares

$52.9 Million
0.0% of portfolio

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $708M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account